EE102 Economic and Organisational Impact of an Innovative Treatment With Extended Durability for Retinal Diseases Reducing the Annual Frequency of Intravitreal Injections in France
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.354
https://www.valueinhealthjournal.com/article/S1098-3015(22)02558-X/fulltext
Title :
EE102 Economic and Organisational Impact of an Innovative Treatment With Extended Durability for Retinal Diseases Reducing the Annual Frequency of Intravitreal Injections in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02558-X&doi=10.1016/j.jval.2022.09.354
First page :
Section Title :
Open access? :
No
Section Order :
12163